CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

International Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 685-694

  Bixby, Dale L ^a   Yannelli, John R ^b,c  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; HLA A2 ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL TRANSPLANTATION; CYTOTOXICITY; HUMAN; IMMUNOGENICITY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD80; CARCINOMA, NON-SMALL-CELL LUNG; CYTOTOXICITY TESTS, IMMUNOLOGIC; HLA-A2 ANTIGEN; HUMANS; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031739066     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981209)78:6<685::AID-IJC4>3.0.CO;2-C     Document Type: Article

References (24)

1. BAIN, C., MERROUCH, Y., PUISIEUX, I., DUC, A., MORIO, P.C. and FAVROT, M., B7.1 gene transduction of human renal-cell-carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cells. Int. J. Cancer, 67, 769-776 (1996).
2. BELL, J.W., Possible immune factors in spontaneous regression of bronchogenic carcinoma: ten year survival in a patient treated with minimal (1,200 rad) radiation alone. Am. J. Surg., 120, 804-806 (1970).
3. DOHRING, C., ANGMAN, L., SPAGNOLI, G. and LANZAVECCHIA, A., T helper and accessory independent cytotoxic responses to human tumor cells transfected with a B7 retroviral vector. Int. J. Cancer, 57, 754-759 (1994).
4. GAZDAR, A.F. and OIE, H.K., Cell culture methods for human lung cancer. Cancer Genet. Cytogenet., 19, 5-10 (1986).
5. KIMURA, H. and YAMAGUCHI, Y., Adjuvant immunotherapy with interleukin-2 and lymphokine activated killer cells after noncurative resection of primary lung cancer. Lung Cancer, 13, 31-44 (1995).
6. LENSCHOW, D.J., WALUNAS, T.L. and BLUESTONE, J.A., CD28/B7 system of T cell costimulation. Ann. Rev. Immunol., 14, 233-258 (1996).
7. MINNA, J.D., SEKIDO, Y., FONG, K.M. and GAZDOR, A.F., Cancer of the lung. In: V.T. De Vita, S. Hellman and S.A. Rosenberg (eds.), Cancer: principles and practice of oncology, pp. 849-911, J.B. Lippincott, Philadelphia (1997).
8. NAKAO, M., YAMANA, H., IMAI, Y., TOH, U., TOH, U., KIMURA, A., YANOMA, S., KAKEGAWA, T. and ITOH, K., HLA-A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma. Cancer Res., 55, 4248-4252 (1995).
9. RATTO, G., ZINO, P., MIRABELLI, S., MINUTI, P., AQUILINA, R., FANTINO, G., SPESSA, E., PONTE, M., BRUZZI, P. and MELIOLI, G., A randomized trial of adoptive immunotherapy with tumor infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer. Cancer, 78, 244-251 (1996).
10. ROSENBERG, S.A., Cell transfer therapy: clinical application. In: V.T. DeVita, S. Hellman and S.A. Rosenberg (eds.), Biological therapy of cancer, pp. 487-507, J.B. Lippincott, Philadelphia (1995).
11. ROSENBERG, S.A., YANNELLI, J.R., YANG, J.C., TOPALIAN, S.L., SCHWARTZENTRUBER, D.J., WEBER, J.S., PARKINSON, D.R., SEIPP, C.A., EINHORN, J.H. and WHITE, D.E., Treatment of patients with metastatic melanoma with autologous tumor infiltrating lymphocytes and interleukin-2. J. nat. Cancer Inst., 86, 1159-1166 (1994).
12. RUCKDESCHEL, J.C., CODISH, S.D., STRANAHAN, A. and MCKNEALLY, M.F., Post-operative empyema improved survival in lung cancer, documentation and analysis of a natural experiment. N. Engl. J. Med., 287, 1013-1017 (1972).
13. SEKI, N., HOSHINO, T., KIKUCHI, M., HAYASHI, A. and ITOH, K.M., HLA-A locus-restricted tumor specific CTLs in tumor infiltrating lymphocytes of patients with non small cell lung cancer. Cell. Immunol., 175, 101-110 (1997).
14. SHICHIJO, S., NAKAO, M., IMAI, Y., TAKASU, H., KAWAMOTO, M., NIIYA, F., YANG, D., TOH, Y., YAMANA, H. and ITOH, K., A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J. exp. Med., 187, 277-288 (1998).
15. SLINGLUFF, C.L., COX, A.L., STOVER, J.M., MOORE, M.M., HUNT, D.F. and ENGELHARD, V.H., Cytotoxic T lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68. Cancer Res., 54, 2731-2737 (1994).
16. STEVENS, E.J., JACKNIN, L., ROBBINS, P.F., KAWAKAMI, Y., EL GAMIL, M., ROSENBERG, S.A. and YANNELLI, J.R., Generation of tumor specific CTL from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines: fine specificity and MART-1 melanoma antigen recognition. J. Immunol., 154, 762-771 (1995).
17. SULE-SUSO, J., ARIENTI, F., MELANI, C., COLOMBO, M.P. and PARMIANI, G., A B7-1 transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes. Europ. J. Immunol., 25, 2737-2742 (1995).
18. + T cells recognize non-mutated HLA-DR restricted tyrosinase epitopes. J. exp. Med., 183, 1965-1971 (1996).
19. + T cells by B7 transfected tumor. Science, 259, 368-370 (1993).
20. WANG, Y.C., ZHU, L., MCHUGH, R., GRAHAM, S.D., HILLYER, C.D., DILLEHAY, D., SELL, K.W. and SEVARAJ, P., Induction of autologous tumor specific cytotoxic T lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD80) costimulation. J. Immunother., 19, 1-8 1996).
21. WEI, Y.Q. and HANG, Z.B., In situ observation of lymphocyte-tumor cell interaction in human lung carcinoma. Immunol. Invest., 18, 1095-1105 (1989).
22. YANG, S., DARROW, T.L. and SEIGLER, H.F., Generation of primary tumor-specific cytotoxic lymphocytes from autologous and human lymphocyte antigen class-I matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells. Cancer Res., 57, 1561-1568 (1997).
23. YANNELLI, J.R., HYATT, C., MCCONNELL, S., HINIES, K., JACKNIN, L., PARKER, L., SANDERS, M. and ROSENBERG, S.A., Growth of tumor infiltrating lymphocytes from human solid cancers: summary of a five year experience. Int. J. Cancer, 65, 413-421 (1996).
24. YOSHINO, I., GOEDEGBUURE, P.S., PEOPLES, G.E., PARIKH, A.S., DlMAlO, J.M., LYERLY, H.K., GAZDAR, A.F. and EBERLEIN, T.J., HER2/neu-derived peptides are shared antigens among human non small cell lung cancer and ovarian cancer. Cancer Res., 54, 3387-3390 (1994).